Deep Intelligence Across Industries

Company Headquarters: Ireland Founded: 1996 Workforce: ~ Company Working: Ryanair DAC operates an ultra-low cost, scheduled-passenger airline serving short-haul, point-to-point routes between Ireland, the UK, Continental Europe, and Morocco. The company provides low-fare airline-related services, scheduled services, ancillary services, car hire services, and other related services to third parties and across a European route network. Ryanair DAC provides its own aircraft and passenger handling and ticketing services at the Dublin Airport.

Wal-Mart Stores, Inc. — CFnB

Magna International Inc. designs, engineers, and manufactures components, assemblies, systems, subsystems, and modules for original equipment manufacturers of vehicles and light trucks worldwide. It operates through four segments: Body Exteriors & Structures, Power & Vision, Seating Systems, and Complete Vehicles. The Body Exteriors & Structures segment provides body and chassis, exterior, and roof systems, as well as battery enclosures and engineering and testing services, including fascia and trims, front end modules, integration panels, liftgate modules, active aerodynamics, engineered glass, running boards, truck bed access products, breakthrough lightings, quarter windows, encapsulated glasses, and side doors. The Power & Vision segment offers ?electric drive systems and components, such as emotors, inverters, onboard chargers, gearboxes, and e-clutch; dedicated hybrid drives, dual and hybrid dual clutch, and manual transmissions; AWD/4WD products and rear drive modules; transmission, driveline components, and ICE; engineering services; advanced driver assistance systems sensors and, and electronic control units; interior and exterior mirrors, camera and driver monitoring systems and electronics, actuators, door handles, and overhead consoles; forward, rear, and auxiliary lighting products; latching, door modules, window, power closure, and hinges and wire forming systems; and modular and textile folding roofs, and hard and soft tops. The Seating Systems segment provides seat structures, mechanism and hardware solutions, and foam and trim products. The Complete Vehicles segment offers vehicle engineering and manufacturing services. The company also designs, engineers, and manufactures tooling products

Company Headquarters: Kaohsiung City, Taiwan Founded: 1980 Company Working: Sunonwealth Electric Machine Industry Co., Ltd. is engaged in the production, sales, and research and development of precision motors, mini fans, and thermal modules. Its products include DC fan & blower series, AC fans, EC fans, fan trays, fan accessories, and ventilation fans. It also provides LED cooling solutions and technology services. The company focuses on the research and development of core motor technology, which enables it to launch numerous patented products. Its product portfolio covers Maglev, the first magnetic levitation motor fan product in the world, Mighty Mini series, the smallest/thinnest fan products in the world, and various thermal modules for LED panels. It offers solutions for clients across various industries such as IT, automobile electronics, optical electronics, and network communication. The company has a research and development team consisting of more than 400 professional engineers and a research and development budget that exceeds 10-12% of its annual turnover. This has enabled the company to obtain a total of 2568 patents worldwide in 2017. It has a global presence in regions such as Asia, the Americas, and Europe.

Company Headquarters: Deeside, UK Founded: 2012 Workforce: NA Company Working: Itaconix PLC (Itaconix), formerly known as Revolymer PLC, manufactures and supplies specialty polymers. Revolymer PLC acquired Itaconix Corporation in 2016 and relaunched as Itaconix PLC in March 2017. Itaconix mostly caters to the home care, personal care, and industrial markets in North America, Europe, and Asia. The company also has distribution channels in 14 countries and collaborations with leading market players such as Akzo Nobel NV, Croda, and Solvay.

1.1.1 Company Overview Headquarters: Carpinteria, California Workforce: 700 Founded: 2004 Company Working: Procore Technologies, Inc., is a leading provider of cloud-based applications for construction. Procore helps in connecting end-users, applications, and devices with the help of a unified platform to enable construction professionals to manage risk and build quality projects within a predetermined budget. The company has a diversified business model with products for Construction Project Management, Construction Financials, Quality & Safety, and Field Productivity. Additionally, the solutions offerings also include standard construction software functionality such as construction project scheduling and job logging and adds automated email, Web-based document sharing, and digital photo archiving. The company has more than 2.5 million users managing billions of dollars in annual construction volume.

Subsea 7 S.A. formed after the merger of Acergy S.A. and Subsea 7 Inc. It is one of the leading companies in manufacturing offshore products and providing services to the energy industry. The company primarily offers offshore pipeline products under the business segment of SURF (subsea umbilical, risers and flowlines) and conventional, renewables and heavy lifting, life of field, and corporate. In the SURF and conventional segment, it offers EPCI works for high complex systems for the offshore application, which primarily include pipelay support vessels (PLSV). It also offers fabrication, installation, extension, and refurbishment services of fixed and floating platforms and associated pipelines for offshore applications. The company offers heavy lifting systems for the oil & gas industry, offshore wind farm foundations, inter-array cables, as well as it offers inspection, and repair and maintenance (IRM) services. The company has a presence in more than 33 countries with actively operating 93 projects, across the globe. In 2018, it spent nearly USD 19.4 million for the research and development activities, which had increased from USD 17.3 million invested in the year 2017.

1.1.1 Company Overview Company Headquarter: U.S. Founded: 1978 Workforce: 9,523 Company Working: Trimble, Inc. engages in the provision of providing positioning, wireless, and software technology solutions. The company operates through various segments such as Geospatial, Resources & Utilities, Buildings & Infrastructure, and Transportation. The company focuses on R&D in order to introduce new products and make improvements in existing products. Due to the strong focus on R&D, the company has been able to launch and commercialize a number of new products in the recent past. In addition, the company's strong R&D has enabled it to add a number of important patents. At the end of FY2016, the company had approximately 1,200 unique issued and enforceable patents, the majority of which cover GNSS based technologies and other applications such as optical and laser technology. In April 2018, Trimble acquired Viewpoint a provider of innovative construction-specific software solutions.

Company Headquarter: Austria Founded: 1938 Workforce: Over 6,400 Company Working: Lenzing AG is an Austria based enterprise, specifically, deals with the production and marketing of textile and nonwoven cellulose fibers and polymer plastics. The company operates through three major segments: fibers, lenzing technique, and other. Fiber is company’s core segment, which almost accounts for the majority of the revenue as of 2018

Ashok Leyland is a flagship of the Hinduja Group and is one of the leading manufacturers of commercial vehicles across the globe. It has formed a joint venture with the Alteams (Finland) for manufacturing high-press die-casting extruded aluminum components for the automotive and telecommunications industries. The company has a large product group for the automotive industry. The company manufactures trucks, buses & commercial vehicles for defense and special applications, and diesel engines for industrial, genset, and marine. It offers its products and services for end-use industries such as automotive, information technology, oil & gas, power, media, entertainment & communications, healthcare, banking & finance services, infrastructure project development, real estate, and trading. Albonair GmbH, Global TVS Bus Body Builders Limited, Hinduja Leyland Finance Limited, and Hinduja Tech Limited are some of its subsidiaries. The company has 9 manufacturing sites across the globe, seven being in India, one in the UK, and one in Ras Al Khaimah (UAE). It has operations in 37 countries worldwide.

Company Headquarters: California, US Founded: 1999 Company Working: Avista Technologies Inc. (Avista Technologies) is operating as a subsidiary of Kurita Water Industries Ltd from May 2019. The company is involved in the development and sale of water treatment chemicals for membrane systems, which include reverse osmosis (RO), microfiltration/ultrafiltration (MF/UF), and multimedia filtration (MMF). It offers coagulants for various applications such as to enhance the process of removal of slit, organics, and colloids; and to reduce turbidity and remove humic & fulvic acid in MMF. It has corporate offices in both the US and UK and distributors and regional offices in over 30 countries. It supplies water treatment chemicals in over 100 countries.

Company Headquarters: Virginia, US Founded: 1968 Company Working: ChemTreat, Inc. (ChemTreat) operates as a wholly owned subsidiary of Danaher. It functions as a part of the environmental & applied solutions business segment of Danaher. It is engaged in the manufacturing and sale of water treatment products. It offers a wide array of products for the prevention of corrosion, scaling, and biofouling in heat transfer systems and advanced polymers for industrial wastewater. It has business presence at various locations in the Americas including Mexico, the US, Canada, Brazil, Chile, Colombia, Ecuador, and Peru.

Company Headquarter: Bad Soden, Germany Founded: 1898 Workforce: 10,000+ Company Working: The Messer Group GmbH is a supplier of industrial gases. Business is focused on 30 European and Asian countries. Messer also sells gases like oxygen, nitrogen, argon, carbon dioxide, hydrogen, helium, shielding gases for industrial use. Messer offers one of the largest product portfolios in the market and develops and optimizes application technologies for gases in state-of-the-art competence centers. The company has presence in the Americas, Europe and Asia.

Company Headquarter: Dublin, Ireland Founded:1879 Workforce:80000 Company Working: Linde is the largest industrial gas company worldwide and is a major technological innovator in the industrial gases industry. Its primary products in its industrial gases business are atmospheric gases (oxygen, nitrogen, argon, and rare gases) and process gases (carbon dioxide, helium, hydrogen, electronic gases, specialty gases, and acetylene). The company also designs and builds equipment that produces industrial gases and offers customers a wide range of gas production and processing services such as olefin plants, natural gas plants, air separation plants, hydrogen and synthesis gas plants and other types of plants. Linde's industrial gases are used in countless applications, from life-saving oxygen for hospitals to high-purity & specialty gases for electronics manufacturing, and hydrogen for clean fuels among others. The company operates in more than 100 countries worldwide with its principal offices in the United Kingdom and United States. In 2018, Praxair, one of the largest industrial gases company in North and South America, and the third-largest worldwide by revenue merged with Linde AG to form Linde plc.

Ballard Power Systems is engaged in designing, developing, manufacturing, selling, and servicing fuel cell products for a variety of applications. It offers heavy-duty modules, fuel cell stacks, backup power systems, portable power systems, unmanned aerial vehicles, and material-handling products. The products and services offered by the company are used in heavy-duty motive power, materials handling, and marine and rail applications. Additionally, it provides technology solutions for engineering and technology transfer services. Furthermore, the company also provides licenses and offer intellectual property to suit various fuel cell applications. Protonex Technology Corporation (US), Idatech (US), Ballard Power Systems Europe A/S (Denmark), Ballard Unmanned Systems, Inc (US), and Ballard Services Inc. (Canada) are some of the company’s subsidiaries. It markets its products in China, Germany, the US, Japan, Belgium, Denmark, the UK, the Netherlands, Canada, Taiwan, France, Poland, Finland, Norway, and Spain.

Alphabet Inc. (Alphabet) is an American multinational company that operates through a collection of businesses of several industries, including technology, life sciences, investment capital, and research. Its subsidiaries include Calico, CapitalG, Chronicle, DeepMind, Google, Google Fiber GV, Jigsaw, Sidewalk Labs, Verily, Waymo, and X, among which Google accounts for the largest share of total revenue generated by Alphabet. In 2016, the net revenue of the company was USD 89.5 billion, which is around 99% of the total revenue of Alphabet, Inc. Google announced its conglomerate to be Alphabet on August 10, 2015. Google is Alphabet’s leading and largest subsidiary. Google, Inc. is a leading technology company specialized in internet-related service and products. It is a wholly owned subsidiary of Alphabet, Inc. Online advertising, search engine, cloud computing, software, and hardware are some of the major specialized products of Google. In retail cloud market, Google offers cloud platform and analytics solution to retail customers. Google is an American multinational company and initially was incorporated as a privately held company. Later, in 2004, the company announced its first public offering. The company offers managed services in terms of work productivity, scheduling, time management, instant messaging, video chats, language translation, mapping, video sharing, notetaking & photo organizing and editing, through its various applications. Google offers Google Search, Google Now, AdWords, AdSense, Double Click Ad Exchange, AdExchange, and AdMob. Google is known to build technology products and provide services to organize information.

Company Headquarter: US Founded: 1991 Workforce: ~16,000 Company Address: Mettler-Toledo, LLC 1900 Polaris Parkway Columbus, OH 43240. Contact Details: Company E-Mail: mary.finnegan@mt.com; Tel: (614) 438-4748, 410 910 8500; Mob: 800 638 8537 Company Working: Mettler-Toledo International, Inc. manufactures and markets precision instruments for use in laboratories and industrial and food retailing. It also provides analytical instruments for use in life sciences, reaction engineering, and real-time analytic systems used in drug and chemical compound development and process analytics instruments used for in-line measurement in production processes. Mettler-Toledo also supplies end-of-line inspection systems used in production and packaging for food, pharmaceutical, and other industries. The company operates through five segments—US operations, Swiss operations, Western European operations, Chinese operations, and others. The US operations segment represents certain of the company's marketing and producing organizations located in the US. The Western European operations segment includes marketing and producing organizations in Western Europe, excluding operations located in Switzerland. The Swiss operations segment includes marketing and producing organizations located in Switzerland as well as extensive R&D operations that are responsible for the development, production, and marketing of precision instruments, including weighing, analytical, and measurement technologies for use in a variety of industrial and laboratory applications. The Chinese operations segment represents marketing and producing organizations located in China. The multi-cuvette spectrophotometers fall under the analytical instruments segment. The company’s market organizations are geographically focused and are responsible for all aspects of the company's sales and service. The Operating segments that exist outside these reportable segments are included in the others segment.

Company Headquarters: US Founded: ~35,700 Workforce: 1999 Company Working: ON Semiconductor Corporation (ON Semiconductor) is a provider of power and signal management, logic, analog, sensors, timing, connectivity, system on chip (SoC), discrete, and custom solutions. It operates through three business segments—power solutions, analog solutions, and image sensors. The power solutions segment offers an array of discrete, modular, and integrated semiconductor products that perform multiple functions, including power switching, signal conditioning, circuit protection, signal amplification, and voltage reference. The analog solutions segment covers analog, mixed-signal and advanced logic application-specific integrated circuits (ASIC), and application-specific standard products (ASSP) solutions mainly used for automotive, consumer electronics, computing, industrial, communications, medical, and aerospace & defense markets. The image sensor group segment includes complementary metal oxide semiconductor and charge-coupled device image sensors, proximity sensors, image signal processors, and actuator drivers for autofocus and image stabilization. The company has design centers, solution engineering centers, and manufacturing facilities in North America, Europe, and Asia. In March 2019, the company acquired Quantenna Communications, a leading provider of Wi-Fi solutions.

Company Headquarter: Oberkochen, Germany Workforce: 26,000+ employees Founded:1996 Company Working: The company is one of the leading manufacturers of optical systems, industrial measurements, and medical devices

Company Headquarters: Osaka, Japan Founded: 1878 Company Working: Shionogi Inc. is a development organization capable of conducting multiple simultaneous late-stage clinical programs and submitting new drug application (NDA) filings worldwide. The company has established commercial capabilities to market their products globally effectively.

### Employee trend (consolidated) *Note: GlobalData reports 1,746 consolidated employees against an unspecified reference date; the company's own outline page reports 1,748 as at 31 March 2026. The parent-company and prior-year headcounts above are drawn from filing aggregator summaries; the precise FY2024 and FY2025 splits should be confirmed against the respective Annual Securities Reports before use in a published document. Headcount has been essentially flat for three years, which is itself the notable fact: Zeria has grown revenue roughly 18% over that period without material headcount addition, with growth carried by European subsidiary productivity and price/mix rather than sales-force expansion.* ### Positioning statement (150 words) Zeria Pharmaceutical is a mid-capitalisation Japanese pharmaceutical company that has executed one of the more complete internationalisation transitions in its peer group. Founded in 1955 around a chondroitin preparation, it built a dual-engine model — prescription gastroenterology plus consumer self-medication — and then, through the 2009 acquisition of Switzerland's Tillotts Pharma AG and the 2020 purchase of Dificlir's European marketing authorisations from Astellas, converted itself from a domestic specialist into a company that now earns 59.3% of revenue outside Japan. Ranked 23rd by revenue among 35 major listed Japanese pharmaceutical companies, it nonetheless posts a 13.9% operating margin that exceeds most similarly sized peers, several of which recorded operating losses in FY2026. The strategic question is no longer whether Zeria can globalise, but whether it can replace Dificlir — its second-largest product, facing patent expiry inside the current medium-term plan — before the earnings contribution rolls off. --- ### 2.1 What the company does Zeria Pharmaceutical researches, develops, manufactures, imports, exports and sells pharmaceuticals, quasi-drugs, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals and reagents; and cosmetics, health foods, alcoholic and soft beverages, food additives, feed, fertiliser, hygiene sundries, medical devices, health equipment, sanitary fixtures, beauty appliances, and measuring and analytical instruments. That is the articles-of-incorporation description; in economic substance the group does two things, and a rounding error. **The prescription business** is a gastroenterology franchise. Zeria describes its ethical-drug strategy as specialising "from research and development through to sales in the gastrointestinal field, covering the upper to lower gastrointestinal tract," with oncology selected as the second focus area behind gastroenterology. In Japan the company fields its own MR (medical representative) organisation through seven branch offices; in Europe it sells through the wholly owned Tillotts Pharma network of nine legal entities; in Asia it exports and works through the Vietnamese subsidiary F.T. Pharma and third-party distributors. **The consumer healthcare business** manufactures, procures and sells OTC medicines, health foods, quasi-drugs and cosmetics supporting self-medication. It is overwhelmingly a Japanese business, anchored on three brand families — Hepalyse (liver-hydrolysate tonics and drinks), Chondroitin (joint and back-pain preparations), and With One (botanical laxatives) — supported by dermatology, oral care, Western herbal medicines and the Iona cosmetics line. **The "Other" segment** is insurance agency and real-estate rental income, generating ¥151m in FY2026 — 0.17% of group revenue. It is not investible and exists largely as a legacy holding structure. ### 2.2 Business model and revenue model Zeria's revenue is essentially 100% product sales. There is no meaningful service, subscription or SaaS-analogue revenue. Licensing income exists but is not separately disclosed at a level suggesting materiality; the Z-338/acotiamide out-licensing programme to Faes Farma, Meiji Seika Pharma, Agastra-Lab and others generates milestone and royalty flows that are absorbed into segment results without separate line-item disclosure. Revenue is recognised on customer acceptance for most transactions, and on shipment for domestic sales where the shipment-to-acceptance interval is normal. Consideration is measured net of returns, discounts and rebates; variable consideration is estimated to the extent significant reversal is improbable. Customer loyalty points issued by certain subsidiaries are identified as separate performance obligations. Consideration is collected within one year, so there is no significant financing component. Two structural features of the model deserve emphasis: **First, the gross margin is very high and the operating margin is not.** FY2026 gross margin was 73.1%; operating margin was 13.9%. The 59-point gap is SG&A, which ran at ¥52,808m, or 59.2% of revenue. This is a marketing-intensive, not a manufacturing-intensive, business. Advertising and promotion alone is budgeted at ¥3,100m for FY2027 against ¥2,440m spent in FY2026 — a 27% planned increase. **Second, a substantial share of the group's economic value sits in acquired intangibles rather than in tangible plant.** At 31 March 2026, intangible fixed assets stood at ¥39,582m — 22% of total assets and 43% above the ¥27,599m carrying value of all tangible fixed assets. Of that, ¥27,089m is *marketing rights* (販売権) and ¥7,822m is *trademarks*. The marketing-rights balance is dominated by the Dificlir authorisations acquired from Astellas. This is the single most important balance-sheet fact about Zeria, and Section 18 returns to it. ### 2.3 Value chain position, customers and end markets Zeria occupies the branded-originator and in-licensor position. It is not a generic manufacturer, not a CDMO, and not a wholesaler. It sits between upstream API and contract manufacturing (a dependency demonstrated in FY2026, when a contract manufacturer's production-equipment fault caused an Asacol supply shortage that suppressed overseas sales through Q3) and downstream distribution. Customer types by channel: - **Japan ethical:** pharmaceutical wholesalers supplying hospitals, clinics and dispensing pharmacies. Reimbursement is set by the national NHI price list, which is revised on a schedule that has become effectively annual — a recurring negative disclosed in every recent results commentary. - **Europe ethical:** national wholesalers and, in tender markets, hospital and payer procurement bodies, served through Tillotts entities in the UK, Ireland, Sweden, Denmark, Germany, France, Spain, Italy and the Czech Republic. - **Japan consumer:** drugstore chains, dispensing pharmacies, convenience-store chains (a distinct and strategically important channel for the Hepalyse W range), general merchandise retailers, and a direct-to-consumer e-commerce operation (Zeria Online). - **Asia:** distributors, plus F.T. Pharma's own domestic Vietnamese channel including a new infusion-solution plant. End markets served: inflammatory bowel disease (ulcerative colitis, Crohn's disease); *Clostridioides difficile* infection; functional dyspepsia; gastritis and peptic ulcer; iron-deficiency anaemia; hyperkalaemia; hypophosphataemia; hypertension; pain and inflammation; ophthalmology; underactive bladder (development stage); non-small-cell lung cancer (development stage); and the Japanese self-medication market across tonics, digestive health, joint health, constipation, cold remedies, dermatology, oral care, femcare and cosmetics. ### 2.4 Independent characterisation Read without the company's framing, Zeria is best understood as a Japanese-listed holding structure around a European specialty gastroenterology business, cross-subsidised and de-risked by a mature, cash-generative Japanese consumer brand portfolio. The numbers support this reading more strongly than the company's own "two wheels of a cart" (車の両輪) balanced-portfolio narrative. In FY2026 the ethical segment produced ¥61,626m of revenue and ¥12,176m of segment profit; consumer healthcare produced ¥27,382m and ¥6,360m. But ethical is where all the growth is (+4.5% versus −2.8%), and within ethical, overseas is where all of *that* growth is: Japan revenue fell 3.4% to ¥36,318m while overseas rose 6.3% to ¥52,841m. The Japanese consumer business is a declining-to-flat annuity that funds European expansion and absorbs corporate overhead; the interesting asset is Tillotts. This matters for valuation because the market appears to be pricing the consolidated entity as a Japanese mid-cap OTC company — 0.85x book, ~9x forward earnings — rather than as a European specialty pharma with a 22% EBITDA margin and a 59% net-debt-to-EBITDA ratio. The counter-argument, which the market may be right about, is the Dificlir patent cliff. ---

Company Headquarter: Memphis, TN Founded: 1950 Workforce: 2,675 employees Company Working: Wright Medical Group N.V. is a global medical device company focused on extremities and biologics. It delivers innovative, value-added solutions improving quality of life for patients worldwide. It is a recognized leader of surgical solutions for upper extremities (shoulder, elbow, wrist, and hand), lower extremities (foot and ankle), and biologics markets.

Company Headquarter: Bengaluru, India Founded: 1992 Workforce: ~160,000 Company Overview: Wipro Limited (Wipro) is one of the leading global information technology, consulting, and business process service company. The company operates through three segments, namely IT services, IT products, and Indian state-run enterprises (ISRE). The IT service business group offers a range of IT and IT-enabled services such as digital strategy advisory, customer-centric design, technology consulting, IT consulting, custom application design, and development. The IT products segment offers a range of third-party IT products such as computing, platforms and storage, networking solutions, enterprise information security and software products, including databases and operating systems which allows us to offer comprehensive IT system integration services. The company offers services related to data, analytics & AI; cloud & infrastructure; consulting; applications; digital operations and platforms; and product engineering. Wipro serves 27 industry verticals some of which includes aerospace & defense, communications, automotive, consumer electronics, healthcare, banking, public sector, semiconductor, and pharmaceutical & life science, and engineering & construction. The company’s strategic focus areas include blockchain, smart machines, human-machine interface (HMI), cognitive computing, and 5G. Wipro has its presence in 50 countries across Europe, the Americas, Asia, and the Middle East and Africa.

Company Headquarter: US Founded: 1840 Workforce: 1000 to 5000 Employees Company Working: Mallinckrodt is a specialty pharmaceuticals company which develops, manufactures, markets, and distributes specialty pharmaceutical drugs and therapies. The company focuses on underserved patients of neurology, rheumatology, nephrology, pulmonology, and ophthalmology. The company also focuses on immunotherapy, neonatal respiratory critical care therapies, analgesics, and gastrointestinal products.

Company Headquarter: Texas, US Founded: 1994 Workforce: 176 Employees Company Working: Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company which focuses on the development and commercialization of pharmaceutical products. The company offers products such as xermelo, an orally-delivered small molecule drug candidate for the treatment of carcinoid syndrome diarrhea in combination with the somatostatin analog therapy in adults and pipeline drug LX1031 and LX 1033 for IBS treatment.

Company Headquarter: Massachusetts, US Founded: 1998 Workforce: 730 Employees Company Working: Ironwood Pharmaceuticals is a commercial biotechnology company. The company commercializes two innovative primary care products, namely, linaclotide, the US branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC), and lesinurad, for the treatment of hyperuricemia associated with gout. It also has a pipeline of innovative product candidates in areas of significant unmet needs, including uncontrolled gastroesophageal reflux disease, diabetic nephropathy, achalasia, heart failure with preserved ejection fraction, and sickle-cell anemia.